BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 36277022)

  • 41. Manifold regularized multitask feature learning for multimodality disease classification.
    Jie B; Zhang D; Cheng B; Shen D;
    Hum Brain Mapp; 2015 Feb; 36(2):489-507. PubMed ID: 25277605
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cognitive signature of brain FDG PET based on deep learning: domain transfer from Alzheimer's disease to Parkinson's disease.
    Choi H; Kim YK; Yoon EJ; Lee JY; Lee DS;
    Eur J Nucl Med Mol Imaging; 2020 Feb; 47(2):403-412. PubMed ID: 31768599
    [TBL] [Abstract][Full Text] [Related]  

  • 43. An Improved Deep Residual Network Prediction Model for the Early Diagnosis of Alzheimer's Disease.
    Sun H; Wang A; Wang W; Liu C
    Sensors (Basel); 2021 Jun; 21(12):. PubMed ID: 34207145
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Multimodal manifold-regularized transfer learning for MCI conversion prediction.
    Cheng B; Liu M; Suk HI; Shen D; Zhang D;
    Brain Imaging Behav; 2015 Dec; 9(4):913-26. PubMed ID: 25702248
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Multiscale deep neural network based analysis of FDG-PET images for the early diagnosis of Alzheimer's disease.
    Lu D; Popuri K; Ding GW; Balachandar R; Beg MF;
    Med Image Anal; 2018 May; 46():26-34. PubMed ID: 29502031
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Radiomics: a novel feature extraction method for brain neuron degeneration disease using
    Li Y; Jiang J; Lu J; Jiang J; Zhang H; Zuo C
    Ther Adv Neurol Disord; 2019; 12():1756286419838682. PubMed ID: 30956687
    [TBL] [Abstract][Full Text] [Related]  

  • 47. FDG-PET for Prediction of AD Dementia in Mild Cognitive Impairment. A Review of the State of the Art with Particular Emphasis on the Comparison with Other Neuroimaging Modalities (MRI and Perfusion SPECT).
    Sanchez-Catasus CA; Stormezand GN; van Laar PJ; De Deyn PP; Sanchez MA; Dierckx RA
    Curr Alzheimer Res; 2017; 14(2):127-142. PubMed ID: 27357645
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Multimodal Discrimination of Alzheimer's Disease Based on Regional Cortical Atrophy and Hypometabolism.
    Yun HJ; Kwak K; Lee JM;
    PLoS One; 2015; 10(6):e0129250. PubMed ID: 26061669
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A Classification Algorithm by Combination of Feature Decomposition and Kernel Discriminant Analysis (KDA) for Automatic MR Brain Image Classification and AD Diagnosis.
    Elahifasaee F; Li F; Yang M
    Comput Math Methods Med; 2019; 2019():1437123. PubMed ID: 32082407
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Anosognosia Is an Independent Predictor of Conversion From Mild Cognitive Impairment to Alzheimer's Disease and Is Associated With Reduced Brain Metabolism.
    Gerretsen P; Chung JK; Shah P; Plitman E; Iwata Y; Caravaggio F; Nakajima S; Pollock BG; Graff-Guerrero A;
    J Clin Psychiatry; 2017; 78(9):e1187-e1196. PubMed ID: 29022655
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Multi-modal discriminative dictionary learning for Alzheimer's disease and mild cognitive impairment.
    Li Q; Wu X; Xu L; Chen K; Yao L; Li R
    Comput Methods Programs Biomed; 2017 Oct; 150():1-8. PubMed ID: 28859825
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Random forest feature selection, fusion and ensemble strategy: Combining multiple morphological MRI measures to discriminate among healhy elderly, MCI, cMCI and alzheimer's disease patients: From the alzheimer's disease neuroimaging initiative (ADNI) database.
    Dimitriadis SI; Liparas D; Tsolaki MN;
    J Neurosci Methods; 2018 May; 302():14-23. PubMed ID: 29269320
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Combination of 18F-FDG PET and cerebrospinal fluid biomarkers as a better predictor of the progression to Alzheimer's disease in mild cognitive impairment patients.
    Choo IH; Ni R; Schöll M; Wall A; Almkvist O; Nordberg A
    J Alzheimers Dis; 2013; 33(4):929-39. PubMed ID: 23047371
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Metabolic correlates of reserve and resilience in MCI due to Alzheimer's Disease (AD).
    Bauckneht M; Chincarini A; Piva R; Arnaldi D; Girtler N; Massa F; Pardini M; Grazzini M; Efeturk H; Pagani M; Sambuceti G; Nobili F; Morbelli S
    Alzheimers Res Ther; 2018 Apr; 10(1):35. PubMed ID: 29615111
    [TBL] [Abstract][Full Text] [Related]  

  • 55. 18F-FDG PET diagnostic and prognostic patterns do not overlap in Alzheimer's disease (AD) patients at the mild cognitive impairment (MCI) stage.
    Morbelli S; Bauckneht M; Arnaldi D; Picco A; Pardini M; Brugnolo A; Buschiazzo A; Pagani M; Girtler N; Nieri A; Chincarini A; De Carli F; Sambuceti G; Nobili F
    Eur J Nucl Med Mol Imaging; 2017 Nov; 44(12):2073-2083. PubMed ID: 28785843
    [TBL] [Abstract][Full Text] [Related]  

  • 56. 18F-Flortaucipir PET Associations with Cerebrospinal Fluid, Cognition, and Neuroimaging in Mild Cognitive Impairment due to Alzheimer's Disease.
    Okafor M; Nye JA; Shokouhi M; Shaw LM; Goldstein F; Hajjar I
    J Alzheimers Dis; 2020; 74(2):589-601. PubMed ID: 32065800
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Amyloid load but not regional glucose metabolism predicts conversion to Alzheimer's dementia in a memory clinic population.
    Frings L; Hellwig S; Bormann T; Spehl TS; Buchert R; Meyer PT
    Eur J Nucl Med Mol Imaging; 2018 Jul; 45(8):1442-1448. PubMed ID: 29546632
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Alzheimer's disease diagnosis framework from incomplete multimodal data using convolutional neural networks.
    Abdelaziz M; Wang T; Elazab A
    J Biomed Inform; 2021 Sep; 121():103863. PubMed ID: 34229061
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Multi-Modality Cascaded Convolutional Neural Networks for Alzheimer's Disease Diagnosis.
    Liu M; Cheng D; Wang K; Wang Y;
    Neuroinformatics; 2018 Oct; 16(3-4):295-308. PubMed ID: 29572601
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The relative importance of imaging markers for the prediction of Alzheimer's disease dementia in mild cognitive impairment - Beyond classical regression.
    Teipel SJ; Kurth J; Krause B; Grothe MJ;
    Neuroimage Clin; 2015; 8():583-93. PubMed ID: 26199870
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.